Yahoo Finance

Cue’s Molecular, Point-of-Care COVID-19 Tests Deployed to Five States in HHS and DOD Pilot Program

SAN DIEGO, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Cue Health Inc. (Cue) announced today that, as of November 9, the U.S. Department of Health and Human Services (HHS) began deploying its molecular, ...
Business Wire

Cue Health Awarded New $28 Million Federal Contract to Develop Flu A/B, RSV, COVID-19 Molecular Multiplex Test for Both Over-the-Counter and Point-of-Care Use

SAN DIEGO--(BUSINESS WIRE)--Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced that it has been awarded a new approximately $28 million contract by the Biomedical Advanced ...
Benzinga.com

Cue’s Scalable Platform Can Meet the Needs of a $180 Billion Diagnostics Market

The global diagnostics market was valued at approximately $180 billion in 2022 and is projected to grow to over $348 billion by 2030. Some of the key drivers of that growth are molecular diagnostics ...
Business Insider

Cue Receives $481 Million Award by DOD and HHS to Expand Domestic Production Capacity and Provide 6 Million Molecular, Point-of-Care COVID-19 Tests

SAN DIEGO, Oct. 13, 2020 /PRNewswire/ -- Cue Health Inc. (Cue) announced today a $481 Million award from the Department of Defense (DOD), on behalf of the U.S. Department of Health and Human Services ...
TechCrunch

Cue Health awarded $13 million government contract to develop portable, point-of-care COVID-19 test

Biotech startup Cue Health has secured a $13 million contract from the U.S. Department of Health and Human Service’s Biomedical Advanced Research and Development Authority (BARDA), which will be used ...